RaySearch Laboratories Unveils Advancements at RSNA
At the upcoming RSNA event, RaySearch Laboratories is excited to showcase its innovative software solutions, particularly focusing on developments in liver ablation therapy. This conference is well-known as a significant platform in the radiology field, and RaySearch aims to attract both existing and potential customers.
Ongoing Developments in Liver Ablation Therapy
RaySearch is dedicated to improving cancer treatment, and their latest liver ablation module is a testament to this commitment. This module incorporates advanced tools like automatic structure segmentation powered by deep learning and virtual applicator placement, which are essential for accurately estimating the ablation zone.
Core Features of the Liver Ablation Module
A highlight of the module includes applicator placement verification, combined with post-treatment checks facilitated through deformable registration techniques. This not only aids in precision but also enhances confidence when performing liver ablation procedures.
Participation in Scientific Sessions at RSNA
RaySearch is set to invite attendees to participate in an interventional radiology session featuring Bruno C. Odisio from MD Anderson. He will be discussing the latest findings from the COVER-ALL study—a randomized trial assessing a novel ablation confirmation method.
Understanding the COVER-ALL Study
This pivotal research investigates the implications of using biomechanical deformable image registration paired with AI-driven autosegmentation, analyzing its effects on minimal ablative margins. This could represent a significant advancement in ensuring optimal treatment outcomes.
Introducing Additional Solutions
At RSNA, RaySearch will also present other groundbreaking solutions, including RayStation® treatment planning system and RayCare® oncology information system. Alongside these, the newly launched DrugLog® verification device will be showcased, aimed at enhancing the accuracy of compounded injectable medications.
DrugLog: Elevating Patient Safety
DrugLog stands as a standalone solution designed to reduce compounding errors by ensuring the correct identification and concentration of medications before they are administered to patients in chemotherapy. This solution aims to bolster pharmacists' confidence in delivering tailored and effective treatments.
Leadership Insights
Johan Löf, the founder and CEO of RaySearch, expressed enthusiasm about meeting with current and prospective clients at the RSNA. He shared that the company looks forward to presenting the exciting developments in liver ablation and broader offerings, such as DrugLog, which demonstrates RaySearch's commitment to expanding their range beyond radiation therapy.
About RaySearch Laboratories
RaySearch Laboratories AB (publ) specializes in developing innovative software solutions tailored to enhance cancer treatments. Its flagship products include the RayStation® treatment planning system and RayCare® oncology information system. The company continually evolves its offerings, now featuring RayIntelligence®, an advanced oncology analytics tool designed to revolutionize how cancer clinics manage data.
Since its inception in 2000 as a spin-off from the Karolinska Institute, RaySearch has built a strong global presence, with over 1,000 clinics across 43 countries. The company has been publicly traded on Nasdaq Stockholm since 2003.
Comprehensive Treatment Planning with RayStation
RayStation® has gained recognition as a premier treatment planning system, employed by leading cancer centers globally. Its unique adaptive therapy capabilities and multi-criteria optimization make it an indispensable tool for effective cancer treatment planning.
Streamlining Oncology Workflows with RayCare
RayCare® oncology information system addresses the complexities faced by modern oncology clinics by providing seamless integration with RayStation®, ensuring efficient coordination of clinical workflows and patient care.
The Era of Data-Driven Oncology with RayIntelligence
RayIntelligence® represents a significant leap forward in healthcare data management. This cloud-based analytics system empowers cancer centers to utilize clinical data effectively, paving the way for more personalized and innovative patient care solutions.
Frequently Asked Questions
What is RaySearch Laboratories focusing on at RSNA?
RaySearch Laboratories will showcase its ongoing developments in liver ablation therapy and present various innovative software solutions aimed at enhancing cancer treatment.
How does the liver ablation module function?
The liver ablation module utilizes deep learning for structure segmentation, virtual applicator placement, and provides tools for verifying applicator placement and treatment outcomes.
What is the COVER-ALL study about?
The COVER-ALL study evaluates a groundbreaking method for ablation confirmation using biomechanical deformable image registration combined with AI-based autosegmentation for better treatment margins.
What products will be highlighted at RSNA?
RaySearch will highlight the RayStation® treatment planning system, RayCare® oncology information system, and the new DrugLog® verification device among other solutions.
What is the mission of RaySearch Laboratories?
RaySearch is dedicated to innovating software solutions that enhance cancer treatment, aiming to improve patient outcomes through advanced technology and data-driven analytics.
